M Trauner
Overview
Explore the profile of M Trauner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meischl T, Balcar L, Park Y, Bucher L, Meier P, Suhr Y, et al.
ESMO Open
. 2024 Jun;
9(6):103593.
PMID: 38848660
Background: Anaemia is frequent in patients with cancer and/or liver cirrhosis and is associated with impaired quality of life. Here, we investigated the impact of anaemia on overall survival (OS)...
2.
Pomej K, Balcar L, Shmanko K, Welland S, Himmelsbach V, Scheiner B, et al.
ESMO Open
. 2023 Feb;
8(1):100783.
PMID: 36753993
Background: There is no clear consensus on the optimal systemic treatment regimen in combined hepatocellular-cholangiocarcinoma (cHCC-CCA) patients. We describe clinical characteristics and outcome of cHCC-CCA patients, with a special focus...
3.
Paternostro R, Sieghart W, Trauner M, Pinter M
ESMO Open
. 2021 Jun;
6(4):100185.
PMID: 34139486
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent and increasing liver disease, which encompasses a variety of liver diseases of different severity. NAFLD can lead to liver cirrhosis with...
4.
Waldmann E, Penz D, Majcher B, Zagata J, Sinkovec H, Heinze G, et al.
United European Gastroenterol J
. 2019 Feb;
7(1):114-124.
PMID: 30788123
Background: Although optimal bowel preparation is essential for high-quality screening colonoscopy, documentation of preparation quality, patient satisfaction and adherence is scarce. Aim: The aim of this article is to compare...
5.
Mandorfer M, Scheiner B, Stattermayer A, Schwabl P, Paternostro R, Bauer D, et al.
Aliment Pharmacol Ther
. 2018 Jun;
48(4):451-459.
PMID: 29956823
Background: The rs738409 C>G p.I148M variant in the patatin-like phospholipase domain containing 3 (PNPLA3)-gene promotes triglyceride accumulation in hepatocytes and hepatic stellate cell activation and has previously been linked to...
6.
Schwarzer R, Kivaranovic D, Paternostro R, Mandorfer M, Reiberger T, Trauner M, et al.
Aliment Pharmacol Ther
. 2018 Mar;
47(8):1162-1169.
PMID: 29492989
Background: Sequential measurements of hepatic venous pressure gradient (HVPG) are used to assess the haemodynamic response to nonselective betablockers (NSBBs) in patients with portal hypertension. Aims: To assess the rates...
7.
Pfisterer N, Dexheimer C, Fuchs E, Bucsics T, Schwabl P, Mandorfer M, et al.
Aliment Pharmacol Ther
. 2018 Feb;
47(7):966-979.
PMID: 29388229
Background: Endoscopic band ligation (EBL) is used for primary (PP) and secondary prophylaxis (SP) of variceal bleeding. Current guidelines recommend combined use of non-selective beta-blockers (NSBBs) and EBL for SP,...
8.
Mandorfer M, Schwabl P, Paternostro R, Pomej K, Bauer D, Thaler J, et al.
Aliment Pharmacol Ther
. 2018 Jan;
47(7):980-988.
PMID: 29377193
Background: Elevated plasma von Willebrand factor antigen (vWF) has been shown to indicate the presence of clinically significant portal hypertension, and thus, predicts the development of clinical events in patients...
9.
Schwarzer R, Kivaranovic D, Mandorfer M, Paternostro R, Wolrab D, Heinisch B, et al.
Aliment Pharmacol Ther
. 2017 Nov;
47(1):86-94.
PMID: 29105115
Background: The amino sulphonic acid taurine reduces oxidative endoplasmatic reticulum stress and inhibits hepatic stellate cell activation, which might lead to reduction of portal pressure in cirrhosis. Aim: To assess...
10.
Erice O, Labiano I, Arbelaiz A, Santos-Laso A, Munoz-Garrido P, Jimenez-Aguero R, et al.
Biochim Biophys Acta Mol Basis Dis
. 2017 Sep;
1864(4 Pt B):1335-1344.
PMID: 28916388
Background And Aims: Cholangiocarcinoma (CCA) is an aggressive tumor type affecting cholangiocytes. CCAs frequently arise under certain cholestatic liver conditions. Intrahepatic accumulation of bile acids may facilitate cocarcinogenic effects by...